Classification of current anticancer immunotherapies

Archive ouverte

Galluzzi, Lorenzo | Vacchelli, Erika | Pedro, José-Manuel Bravo-San | Buqué, Aitziber | Senovilla, Laura | Baracco, Elisa Elena | Bloy, Norma | Castoldi, Francesca | Abastado, Jean-Pierre | Agostinis, Patrizia | Aranda, Fernando | Ayyoub, Maha | Beckhove, Philipp | Blay, Jean-Yves | Bracci, Laura | Caignard, Anne | Castelli, Chiara | Cavallo, Federica | Celis, Estaban | Cerundolo, Vincenzo | Clayton, Aled | Colombo, Mario, P | Coussens, Lisa | Dhodapkar, Madhav, V | Eggermont, Alexander, M | Fearon, Douglas, T | Fridman, Wolf, H | Fučíková, Kitka | Gabrilovich, Dmitry, I | Galon, Jérôme | Garg, Abhishek | Ghiringhelli, François | Giaccone, Giuseppe | Gilboa, Eli | Gnjatic, Sacha | Hoos, Axel | Hosmalin, Anne | Jäger, Dirk | Kalinski, Pawel | Kärre, Klas | Kepp, Oliver | Kiessling, Rolf | Kirkwood, John, J | Klein, Eva | Knuth, Alexander | Lewis, Claire, E | Liblau, Roland | Lotze, Michael, T | Lugli, Enrico | Mach, Jean-Pierre | Mattei, Fabrizio | Mavilio, Domenico | Melero, Ignacio | Melief, Cornelis, J | Mittendorf, Elizabeth, A | Moretta, Lorenzo | Odunsi, Adekunke | Okada, Hideho | Paluka, Anna Karolina | Peter, Marcus, E | Pienta, Kenneth, J | Porgador, Angel | Prendergast, George, C | Rabinovich, Gabriel, A | Restifo, Nicholas, P | Rizvi, Naiyer | Sautès-Fridman, Catherine | Schreiber, Hans | Seliger, Barbara | Shiku, Hiroshi | Silva-Santos, Bruno | Smyth, Mark, J | Speiser, Daniel, A | Spisek, Radek | Srivastava, Pramod, K | Talmadge, James, E | Tartour, Eric | van Der Burg, Sjoerd, H | van den Eynde, Benoît, J | Vile, Richard | Wagner, Hermann | Weber, Jeffrey, S | Whiteside, Theresa, L | Wolchok, Jedd, D | Zitvogel, Laurence | Zou, Weiping | Kroemer, Guido

Edité par CCSD ; Impact journals -

International audience. NA

Suggestions

Du même auteur

Consensus nomenclature for CD8+ T cell phenotypes in cancer

Archive ouverte | Apetoh, Lionel | CCSD

International audience. Whereas preclinical investigations and clinical studies have established that CD8+ T cells can profoundly affect cancer progression, the underlying mechanisms are still elusive. Challenging t...

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Archive ouverte | Buqué, Aitziber | CCSD

International audience. An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Archive ouverte | Buqué, Aitziber | CCSD

International audience. Abstract Hormone receptor (HR) + breast cancer (BC) causes most BC-related deaths, calling for improved therapeutic approaches. Despite expectations, immune checkpoint blockers (ICBs) are poo...

Chargement des enrichissements...